货号:GS40364
Larcaviximab (also known as c4G7-N) is an IgG1κ chimeric monoclonal antibody specifically developed against the glycoprotein of the Ebola virus. As an IgG1 isotype, it is designed to neutralize the virus and may also engage effector immune functions. It is part of a broader experimental strategy to develop antibody-based therapies for the treatment and prevention of Ebola virus disease, often studied in combination with other monoclonal antibodies in therapeutic cocktails.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物